EGFR Exon 19 (Deletion)

About

Biomarker type: Somatic variant

Gene context: EGFR

Mappings
View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (2) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Dacomitinib
FDA (2) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Erlotinib
FDA (2) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Gefitinib
EMA (2) FDA (6) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Osimertinib
FDA (2) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Carboplatin, Osimertinib, Pemetrexed
FDA (2) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Cisplatin, Osimertinib, Pemetrexed
FDA (2) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Erlotinib, Ramucirumab
EMA (3) FDA (4) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Amivantamab, Lazertinib
EMA (1) FDA (2) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Amivantamab, Carboplatin, Pemetrexed
EMA (1) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Bevacizumab, Erlotinib
EMA (1) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Cisplatin, Osimertinib
EMA (1) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Carboplatin, Osimertinib
FDA (2) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Datopotamab deruxtecan
EMA (1) EGFR Exon 19 (Deletion) Non-Small Cell Lung Cancer Aumolertinib